Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 454 of 5804
-
New shigella vaccine shows promise for infants in phase 2 trial
⭐️ VACCINE ⭐️ CompletedIn this study, the second-generation tetravalent bioconjugate candidate vaccine Shigella4V2 will be tested to confirm data on its safety and immunogenicity in infants and to identify the best dose of Shigella4V2 in 9-month-old infants.
Phase: PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:03 UTC
-
Handheld ultrasound + AI could bring breast cancer screening to remote areas
Diagnosis OngoingThe high cost of diagnostic equipment, limited expertise, and inadequate infrastructure are major barriers to early breast cancer diagnosis in low- and middle-income countries. Point-of-care ultrasound (POCUS) offers a relatively low-cost, portable solution that, when combined wi…
Phase: NA • Sponsor: Region Skane • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New obesity pill shows promise in early trial
Disease control CompletedTo evaluate the efficacy of HRS9531 tablet compared with placebo in reducing body weight in obese subjects after 26 weeks of treatment.
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for heart lining pain: can CardiolRx keep flare-ups away?
Disease control Recruiting nowMulti-center, randomized, double-blind, placebo-controlled, phase-3 Trial. Patients with a history of recurrent pericarditis who are being treated with an IL-1 blocker for at least 12 months, scheduled to be discontinued, will be approached for potential trial participation. Dou…
Phase: PHASE3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a simple gas help heal the brain after injury?
Disease control ENROLLING_BY_INVITATIONTraumatic brain injury (TBI) causes acute deficits in cerebral perfusion which may lead to secondary injury and worse outcomes. Inhaled nitric oxide (iNO) is a vasodilator that increases cerebral blood flow and is clinically used for hypoxic respiratory failure in neonates and ad…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple ear clip tame brain swelling after a stroke?
Disease control Recruiting nowThis study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New radiation schedule tested to improve esophageal cancer treatment
Disease control Recruiting nowThis is a prospective, open-label, randomized phase II clinical trial designed to compare the efficacy and toxicity of hypofractionated concurrent chemoradiotherapy versus conventional fractionated concurrent chemoradiotherapy following induction chemoimmunotherapy in patients wi…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New pill could let Sun-Sensitive patients enjoy the outdoors
Disease control OngoingThe goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to answer are: * Whether bitopertin increases pain-free sunlight exposure after 6 months of treatment in participants wit…
Phase: PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Shockwave therapy could crack tough heart blockages
Disease control Recruiting nowThe FORWARD CAD IDE Study is a Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study conducted to assess the safety and effectiveness of the Shockwave Intravascular Lithotripsy (IVL) System with the Javelin Coronary IVL Catheter for the treatment of c…
Phase: NA • Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for Hard-to-Treat uterine and cervical cancers
Disease control Recruiting nowThe researchers are doing this study to find out if ivonescimab is an effective treatment for people with endometrial cancer (EC) and/or cervical cancer (CC). The researchers will also look at whether the study drug is safe and causes few or mild side effects in participants.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Promising new shingles vaccine enters human trials
⭐️ VACCINE ⭐️ Recruiting nowThe purpose of this clinical study is to evaluate the safety and immunogenicity of receiving two doses of recombinant herpes zoster vaccine (CHO cells) (RHZV) in healthy individuals aged 40 years and above. This study will be conducted in 2 substudies: Substudy A (Phase I) and Su…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
Can a Family-Based program reduce depression and abuse in young nepali wives?
Disease control Recruiting nowIntimate Partner Violence (IPV) is a major public health problem in low- and middle-income countries (LMICs). Globally, an estimated 30% of women report physical or sexual violence by an intimate partner in their lifetime. IPV is a well-established social driver of mental health …
Phase: NA • Sponsor: Possible • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a simple blood test predict leukemia risk after cancer therapy?
Knowledge-focused Recruiting nowThe goal of the Clonal Hematopoiesis Chemotherapy and Radiation Effects (CH CARE) Study is to understand how the presence or absence of clonal hematopoiesis (CH) influences outcomes in people receiving chemotherapy and radiation for solid cancers. The study will collect biospeci…
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Ear-Worn gadget aims to predict seizures before they start
Diagnosis Recruiting nowThe proposed study is an investigator-initiated study that aims to measure the accuracy of a wearable seizure detection and prediction device (Ear-Seizure Detection Device (EarSD)) by simultaneous recording with conventional video-EEG (Electroencephalogram) on patients with epile…
Phase: NA • Sponsor: Felicia Chu • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Immune cell therapy takes on untreatable liver cancer
Disease control OngoingThis is a Phase 1b study of GKL-006 Injection in patients with unresectable hepatocellular carcinoma.
Phase: PHASE1 • Sponsor: Beijing Gene Key Life Technology Co., Ltd • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis is a single-arm, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of Anti-HER2 CAR-T cell injection in patients with HER2-positive advanced malignant solid tumors.
Phase: NA • Sponsor: UTC Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a diabetes drug stop AFib from coming back?
Disease control Recruiting nowObjective: The purpose of this study is to determine if there is a difference in the recurrence rate of atrial fibrillation (AF) between a group of patients with AF and heart failure undergoing catheter ablation who are administered the SGLT2 inhibitor, Enavogliflozin, and a cont…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy aims to control advanced breast cancer
Disease control Recruiting nowPhase I: Characterize safety and tolerability of ECI830 as a single agent and in combination with ribociclib and fulvestrant. Identify dose range for optimization/recommended dose for future studies. Phase II: Assess the anti-tumor activity of ECI830 in combination with ribocicl…
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help surgeons remove all prostate cancer
Diagnosis Recruiting nowThis study is being done to compare how well Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging may improve the detection of malignant (growing in an uncontrolled way) tissue in adult subjects undergoing prostatectomy and lymph node dissection for bio…
Phase: PHASE2 • Sponsor: Clinton Bahler • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New scan could spot cancer spread sooner, boosting survival
Knowledge-focused Recruiting nowSeveral studies have shown improved sensitivity of FDG-PET/CT compared with conventional imaging for diagnosing metastatic breast cancer in retrospective and smaller prospective studies. For response monitoring, we expect FDG-PET/CT to detect disease progression earlier than CT i…
Phase: NA • Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC